A BELFAST-based data analytics firm is launching a new regional hub in Asia.
Diaceutics, founded by Belfast native Peter Keeling, is opening an Asia headquarters in Singapore as part of international growth plans.
The company is the world’s leading provider of precision medicine data analytics, software and service solutions
and works with the pharmaceutical industry to further the application of precision medicine - an approach which tailors medical treatments to the individual characteristics of each patient.
Diaceutics Asia is building an initial team of six – consisting of lab directors, data scientists and sales personnel – working to reinforce its presence and patient impact in Asia.
The company already has offices in Belfast, Dundalk and in the US.
Damian Thornton, COO of Diaceutics said the new Asia base is a natural step for the company.
"Singapore provides the ideal hub from which to ramp up our work in Asia," he said.
We are excited to have a very skilled team of scientists and business people, who share the company’s vision of helping to improve patient outcomes through better testing."
With more than 10 per cent of the company’s annual revenues now coming from the Asian market, the announcement represents Diaceutics’ first official move into the continent.
Diaceutics estimates that there are currently more than 300 targeted oncology drugs in late stage development across the major Asian markets and from its new base the company will be able to support the launch of and access to precision therapies in China, Japan, Hong Kong, South Korea, Thailand and Taiwan.
Diaceutics currently works with 166 laboratories across Asia. and will expand its network as a result of the new regional hub.
